Nagaraj S Nagathihalli

8PUBLICATIONS
39CO-AUTHORS
Molecular targetsCancer diagnosisCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 15, 2025
Targeting CREB remodels the immune microenvironment to enhance immunotherapy responses in pancreatic cancer.

Siddharth Mehra, Supriya Srinivasan, Sudhakar Jinka

|Jun 21, 2024
CREB drives acinar cells to ductal reprogramming and promotes pancreatic cancer progression in preclinical models of alcoholic pancreatitis.

Supriya Srinivasan, Siddharth Mehra, Sudhakar Jinka

|Jun 10, 2024
Cell-specific nanoengineering strategy disrupts tolerogenic signaling from myeloid-derived suppressor cells to invigorate antitumor immunity in pancreatic cancer.

Nilesh U Deshpande, Anna Bianchi, Haleh Amirian

|Jan 29, 2024
Tumor Cell-Intrinsic p38 MAPK Signaling Promotes IL1α-Mediated Stromal Inflammation and Therapeutic Resistance in Pancreatic Cancer.

Samara P Singh, Austin R Dosch, Siddharth Mehra

|Jul 14, 2023
Remodeling of Stromal Immune Microenvironment by Urolithin A Improves Survival with Immune Checkpoint Blockade in Pancreatic Cancer.

Siddharth Mehra, Vanessa T Garrido, Austin R Dosch

|Mar 22, 2023
Cell-Autonomous Cxcl1 Sustains Tolerogenic Circuitries and Stromal Inflammation via Neutrophil-Derived TNF in Pancreatic Cancer.

Anna Bianchi, Iago De Castro Silva, Nilesh U Deshpande

Pageof 2

Frequent Collaborators

5 joint publications

Jashodeep Datta

4 joint publications

Nipun Merchant

4 joint publications

Yuguang Ban

3 joint publications

Iago De Castro Silva